Enthorin Therapeutics

Breakthrough Therapeutics Targeting Brain Dysfunction Enthorin Therapeutics is a clinical stage pharmaceutical company founded with the goal of developing innovative therapeutics that target brain circuit dysfunction to improve quality of life for patients, families, and communities. Founders Co-Founder J. Guy Breitenbucher, Ph.D. Former Head of Discovery Chemistry at Dart Neuroscience, and former Head of Pain